When the body's defense system mistakes muscle tissue for a foreign invader
In short: Dermatomyositis is a complex autoimmune condition where the immune system mistakenly attacks the body's own muscles and skin. While it often presents as a visible rash, the underlying mechanism involves a systemic inflammatory process that can lead to significant muscle disability and serious internal complications.
Dermatomyositis is characterized by an immune-mediated microangiopathy, where inflammation attacks tissues through the type I interferon signaling pathway. This process causes the production of specific antibodies that target muscle tissue, leading to hallmark symptoms: a dusky red or violet rash and proximal muscle weakness. The rash typically appears on the face, eyelids, knuckles, elbows, knees, chest, and back, though it may be harder to see on darker skin tones.
The disease affects both adults and children, though it typically appears in adults between their late 40s and early 60s, and in children between ages 5 and 15. While there is currently no cure, treatments aim to improve muscle strength and clear skin lesions. A critical aspect of modern management is the 'clinico-serological model,' which uses myositis-specific autoantibodies to define different phenotypes. For example, anti-TIF1γ and anti-NXP2 antibodies are linked to a high risk of malignancy, while anti-MDA5 antibodies can signal a risk for rapidly progressive interstitial lung disease.
Beyond skin and muscle, the condition can cause severe systemic morbidity. It may affect the esophagus, leading to dysphagia (trouble swallowing), which can cause weight loss or aspiration pneumonia. It can also impact the chest muscles, potentially resulting in shortness of breath or respiratory failure. Adults must undergo a compulsory, risk-based cancer screening during early treatment due to the known possibility of hidden tumours. Treatment has evolved from standard corticosteroids to targeted therapies like rituximab and Janus kinase inhibitors.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Dermatomyositis Overview
- Also: Dermatomyositis-Dermatomyositis - Symptoms & causes - Mayo Clinic
- Also: Dermatomyositis: A Narrative Review of Skin as a Window to Muscle and Malignancy
To cite this card, link to https://intellectplus.co.uk/app/science-dermatomyositis-overview.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Science · Latest · A–Z · All topics
